1
|
Moutaharrik S, Maroni A, Neut C, Dubuquoy C, Dubuquoy L, Foppoli A, Cerea M, Palugan L, Siepmann F, Siepmann J, Gazzaniga A. In vitro and in vivo evaluation of a pH-, microbiota- and time-based oral delivery platform for colonic release. Eur J Pharm Biopharm 2023; 183:13-23. [PMID: 36563887 DOI: 10.1016/j.ejpb.2022.12.013] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2022] [Revised: 12/10/2022] [Accepted: 12/18/2022] [Indexed: 12/24/2022]
Abstract
Several formulation strategies have been proposed for oral colon delivery, particularly for the therapy of inflammatory bowel disease (IBD). However, targeting the large intestine remains a challenging goal. The aim of this study was to develop and evaluate a novel type of drug delivery system, which is based on multiple drug release triggers for reliable performance. The system consists of: (i) a drug core, (ii) an inner swellable low-viscosity hydroxypropyl methylcellulose (HPMC) layer, and (iii) an outer film coating based on a Eudragit® S:high-methoxyl (HM) pectin (7:3 w/w) blend, optionally containing chitosan. Convex immediate release tablets (2 or 4 mm in diameter) containing paracetamol or 5-aminosalicylic acid (5-ASA) were coated in a fluid bed. The double-coated tablets exhibited pulsatile release profiles when changing the release medium from 0.1 N HCl to phosphate buffer pH 7.4. Also, drug release was faster in simulated colonic fluid (SCF) in the presence of fecal bacteria from IBD patients compared to control culture medium from tablets with outer Eudragit® S: HM pectin: chitosan coatings. The latter systems showed promising results in the control of the progression of colitis and alteration of the microbiota in a preliminary rat study.
Collapse
Affiliation(s)
- S Moutaharrik
- Università degli Studi di Milano, Dipartimento di Scienze Farmaceutiche (DISFARM), Sezione di Tecnologia e Legislazione Farmaceutiche "Maria Edvige Sangalli", 20133 Milan, Italy.
| | - A Maroni
- Università degli Studi di Milano, Dipartimento di Scienze Farmaceutiche (DISFARM), Sezione di Tecnologia e Legislazione Farmaceutiche "Maria Edvige Sangalli", 20133 Milan, Italy.
| | - C Neut
- University of Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France.
| | - C Dubuquoy
- University of Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France.
| | - L Dubuquoy
- University of Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France.
| | - A Foppoli
- Università degli Studi di Milano, Dipartimento di Scienze Farmaceutiche (DISFARM), Sezione di Tecnologia e Legislazione Farmaceutiche "Maria Edvige Sangalli", 20133 Milan, Italy.
| | - M Cerea
- Università degli Studi di Milano, Dipartimento di Scienze Farmaceutiche (DISFARM), Sezione di Tecnologia e Legislazione Farmaceutiche "Maria Edvige Sangalli", 20133 Milan, Italy.
| | - L Palugan
- Università degli Studi di Milano, Dipartimento di Scienze Farmaceutiche (DISFARM), Sezione di Tecnologia e Legislazione Farmaceutiche "Maria Edvige Sangalli", 20133 Milan, Italy.
| | - F Siepmann
- University of Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France.
| | - J Siepmann
- University of Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France.
| | - A Gazzaniga
- Università degli Studi di Milano, Dipartimento di Scienze Farmaceutiche (DISFARM), Sezione di Tecnologia e Legislazione Farmaceutiche "Maria Edvige Sangalli", 20133 Milan, Italy.
| |
Collapse
|
2
|
Gougelet A, Torre C, Veber P, Sartor C, Bachelot L, Denechaud PD, Godard C, Moldes M, Burnol AF, Dubuquoy C, Terris B, Guillonneau F, Ye T, Schwarz M, Braeuning A, Perret C, Colnot S. T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice. Hepatology 2014; 59:2344-57. [PMID: 24214913 DOI: 10.1002/hep.26924] [Citation(s) in RCA: 115] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/16/2013] [Accepted: 11/06/2013] [Indexed: 12/21/2022]
Abstract
UNLABELLED β-catenin signaling can be both a physiological and oncogenic pathway in the liver. It controls compartmentalized gene expression, allowing the liver to ensure its essential metabolic function. It is activated by mutations in 20%-40% of hepatocellular carcinomas (HCCs) with specific metabolic features. We decipher the molecular determinants of β-catenin-dependent zonal transcription using mice with β-catenin-activated or -inactivated hepatocytes, characterizing in vivo their chromatin occupancy by T-cell factor (Tcf)-4 and β-catenin, transcriptome, and metabolome. We find that Tcf-4 DNA bindings depend on β-catenin. Tcf-4/β-catenin binds Wnt-responsive elements preferentially around β-catenin-induced genes. In contrast, genes repressed by β-catenin bind Tcf-4 on hepatocyte nuclear factor 4 (Hnf-4)-responsive elements. β-Catenin, Tcf-4, and Hnf-4α interact, dictating β-catenin transcription, which is antagonistic to that elicited by Hnf-4α. Finally, we find the drug/bile metabolism pathway to be the one most heavily targeted by β-catenin, partly through xenobiotic nuclear receptors. CONCLUSIONS β-catenin patterns the zonal liver together with Tcf-4, Hnf-4α, and xenobiotic nuclear receptors. This network represses lipid metabolism and exacerbates glutamine, drug, and bile metabolism, mirroring HCCs with β-catenin mutational activation.
Collapse
Affiliation(s)
- Angélique Gougelet
- Institut Cochin, Université Paris Descartes, Centre National de la Recherche Scientifique (CNRS), UMR8104, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM), U1016, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Dubuquoy C, Burnol AF, Moldes M. PNPLA3, a genetic marker of progressive liver disease, still hiding its metabolic function? Clin Res Hepatol Gastroenterol 2013; 37:30-5. [PMID: 22884299 DOI: 10.1016/j.clinre.2012.06.014] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/10/2012] [Revised: 06/14/2012] [Accepted: 06/20/2012] [Indexed: 02/04/2023]
Abstract
Non-alcoholic fatty liver disease (NAFLD) is an emerging epidemic disease. It represents a large spectrum of liver diseases, and affects both adults and children. The etiology of NAFLD is multifactorial. Indeed, several events such as caloric imbalance including sedentary lifestyle, obesity and/or a predisposing genetic background are key players in the increasing risk for NAFLD development and its progression. Recently, a sequence variation within the gene encoding for patatin-like phospholipase containing 3 (PNPLA3, rs738409) was found to modulate steatosis, inflammation and fibrosis in NAFLD. It was also demonstrated as a novel genetic marker associated with progressive ALD (alcoholic liver disease). In this mini-review, we summarize the current knowledge on (i) PNPLA3 variant(s) in the pathogenesis of liver diseases, and (ii) PNPLA3 gene regulation and potential function in liver.
Collapse
|
4
|
Dubuquoy C, Robichon C, Lasnier F, Langlois C, Dugail I, Foufelle F, Girard J, Burnol AF, Postic C, Moldes M. Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes. J Hepatol 2011; 55:145-53. [PMID: 21145868 DOI: 10.1016/j.jhep.2010.10.024] [Citation(s) in RCA: 107] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/14/2010] [Revised: 09/30/2010] [Accepted: 10/19/2010] [Indexed: 02/08/2023]
Abstract
BACKGROUND & AIMS The adiponutrin/PNPLA3 (patatin-like phospholipase domain-containing protein 3) variant I148M has recently emerged as an important marker of human fatty liver disease. In order to understand the role of the adiponutrin/PNPLA3 protein, we investigated the regulation of its expression in both human and mouse hepatocytes. METHODS Adiponutrin/PNPLA3 and lipogenic enzyme expression was determined by real-time PCR analysis in a wide panel of analysis in vivo in the mouse liver and in vitro in murine hepatocytes and human hepatocyte cell lines infected with ChREBP or SREBP1c-expressing adenoviruses. RESULTS We show that in the mouse liver, adiponutrin/PNPLA3 gene expression is under the direct transcriptional control of ChREBP (carbohydrate-response element-binding protein) and SREBP1c (sterol regulatory element binding protein1c) in response to glucose and insulin, respectively. In silico analysis revealed the presence of a ChoRE (carbohydrate response element) and of a SRE (sterol response element) binding site on the mouse adiponutrin/PNPLA3 gene promoter. Point mutation analysis in reporter gene assays identified the functional response of these two binding sites in the mouse adiponutrin/PNPLA3 promoter. In contrast, in human immortalized hepatocytes and in HepG2 hepatoma cells, only SREBP1c was able to induce adiponutrin/PNPLA3 expression, whereas ChREBP was unable to modulate its expression. CONCLUSIONS All together, our results suggest that adiponutrin/PNPLA3 is regulated by two key factors of the glycolytic and lipogenic pathways, raising the question of its implication in the metabolism of carbohydrates and lipids.
Collapse
|
5
|
Guinez C, Filhoulaud G, Rayah-Benhamed F, Marmier S, Dubuquoy C, Dentin R, Moldes M, Burnol AF, Yang X, Lefebvre T, Girard J, Postic C. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 2011; 60:1399-413. [PMID: 21471514 PMCID: PMC3292313 DOI: 10.2337/db10-0452] [Citation(s) in RCA: 159] [Impact Index Per Article: 12.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
OBJECTIVE Carbohydrate-responsive element-binding protein (ChREBP) is a key transcription factor that mediates the effects of glucose on glycolytic and lipogenic genes in the liver. We have previously reported that liver-specific inhibition of ChREBP prevents hepatic steatosis in ob/ob mice by specifically decreasing lipogenic rates in vivo. To better understand the regulation of ChREBP activity in the liver, we investigated the implication of O-linked β-N-acetylglucosamine (O-GlcNAc or O-GlcNAcylation), an important glucose-dependent posttranslational modification playing multiple roles in transcription, protein stabilization, nuclear localization, and signal transduction. RESEARCH DESIGN AND METHODS O-GlcNAcylation is highly dynamic through the action of two enzymes: the O-GlcNAc transferase (OGT), which transfers the monosaccharide to serine/threonine residues on a target protein, and the O-GlcNAcase (OGA), which hydrolyses the sugar. To modulate ChREBP(OG) in vitro and in vivo, the OGT and OGA enzymes were overexpressed or inhibited via adenoviral approaches in mouse hepatocytes and in the liver of C57BL/6J or obese db/db mice. RESULTS Our study shows that ChREBP interacts with OGT and is subjected to O-GlcNAcylation in liver cells. O-GlcNAcylation stabilizes the ChREBP protein and increases its transcriptional activity toward its target glycolytic (L-PK) and lipogenic genes (ACC, FAS, and SCD1) when combined with an active glucose flux in vivo. Indeed, OGT overexpression significantly increased ChREBP(OG) in liver nuclear extracts from fed C57BL/6J mice, leading in turn to enhanced lipogenic gene expression and to excessive hepatic triglyceride deposition. In the livers of hyperglycemic obese db/db mice, ChREBP(OG) levels were elevated compared with controls. Interestingly, reducing ChREBP(OG) levels via OGA overexpression decreased lipogenic protein content (ACC, FAS), prevented hepatic steatosis, and improved the lipidic profile of OGA-treated db/db mice. CONCLUSIONS Taken together, our results reveal that O-GlcNAcylation represents an important novel regulation of ChREBP activity in the liver under both physiological and pathophysiological conditions.
Collapse
Affiliation(s)
- Céline Guinez
- INSERM, U1016, Institut Cochin, Paris, France
- Centre National de la Recherche Scientifique, UMR 8104, Paris, France
- Department of Endocrinology, Metabolism and Cancer, Université Paris-Descartes, Paris, France
| | - Gaëlle Filhoulaud
- INSERM, U1016, Institut Cochin, Paris, France
- Centre National de la Recherche Scientifique, UMR 8104, Paris, France
- Department of Endocrinology, Metabolism and Cancer, Université Paris-Descartes, Paris, France
| | - Fadila Rayah-Benhamed
- INSERM, U1016, Institut Cochin, Paris, France
- Centre National de la Recherche Scientifique, UMR 8104, Paris, France
- Department of Endocrinology, Metabolism and Cancer, Université Paris-Descartes, Paris, France
| | - Solenne Marmier
- INSERM, U1016, Institut Cochin, Paris, France
- Centre National de la Recherche Scientifique, UMR 8104, Paris, France
- Department of Endocrinology, Metabolism and Cancer, Université Paris-Descartes, Paris, France
| | - Céline Dubuquoy
- INSERM, U1016, Institut Cochin, Paris, France
- Centre National de la Recherche Scientifique, UMR 8104, Paris, France
- Department of Endocrinology, Metabolism and Cancer, Université Paris-Descartes, Paris, France
| | - Renaud Dentin
- INSERM, U1016, Institut Cochin, Paris, France
- Centre National de la Recherche Scientifique, UMR 8104, Paris, France
- Department of Endocrinology, Metabolism and Cancer, Université Paris-Descartes, Paris, France
| | - Marthe Moldes
- INSERM, U1016, Institut Cochin, Paris, France
- Centre National de la Recherche Scientifique, UMR 8104, Paris, France
- Department of Endocrinology, Metabolism and Cancer, Université Paris-Descartes, Paris, France
| | - Anne-Françoise Burnol
- INSERM, U1016, Institut Cochin, Paris, France
- Centre National de la Recherche Scientifique, UMR 8104, Paris, France
- Department of Endocrinology, Metabolism and Cancer, Université Paris-Descartes, Paris, France
| | - Xiaoyong Yang
- Department of Comparative Medicine, Yale School of Medicine, New Haven, Connecticut
| | - Tony Lefebvre
- Unit of Structural and Functional Glycobiology, UMR 8576, Centre National de la Recherche Scientifique, Université des Sciences et Technologies de Lille 1, Villeneuve d'Ascq, France
| | - Jean Girard
- INSERM, U1016, Institut Cochin, Paris, France
- Centre National de la Recherche Scientifique, UMR 8104, Paris, France
- Department of Endocrinology, Metabolism and Cancer, Université Paris-Descartes, Paris, France
| | - Catherine Postic
- INSERM, U1016, Institut Cochin, Paris, France
- Centre National de la Recherche Scientifique, UMR 8104, Paris, France
- Department of Endocrinology, Metabolism and Cancer, Université Paris-Descartes, Paris, France
- Corresponding author: Catherine Postic,
| |
Collapse
|
6
|
Dubuquoy C, Guillaumont R., Bouissieres G. Extraction d'éléments mono-, di- et tri-valents dans divers solvants en présence d'acide di-2-éthylhexylphosphorique. RADIOCHIM ACTA 2009. [DOI: 10.1524/ract.1967.8.1.49] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
- C. Dubuquoy
- Commissariat à l'Energie Atomique, Département des Radioelements, Centre d'Etudes Nucleaires de Saclay (91) et Institut de Physique Nucleaire, Division de Radiochimie, Arcueil (94)
- Pour des raisons de simplification, nous désignerons par HA la molécule d'acide dialcoylphosphorique, par A- sa forme ionisee et par M2+ le cation envisagé
| | - R . Guillaumont
- Commissariat à l'Energie Atomique, Département des Radioelements, Centre d'Etudes Nucleaires de Saclay (91) et Institut de Physique Nucleaire, Division de Radiochimie, Arcueil (94)
- Pour des raisons de simplification, nous désignerons par HA la molécule d'acide dialcoylphosphorique, par A- sa forme ionisee et par M2+ le cation envisagé
| | - G. Bouissieres
- Commissariat à l'Energie Atomique, Département des Radioelements, Centre d'Etudes Nucleaires de Saclay (91) et Institut de Physique Nucleaire, Division de Radiochimie, Arcueil (94)
- Pour des raisons de simplification, nous désignerons par HA la molécule d'acide dialcoylphosphorique, par A- sa forme ionisee et par M2+ le cation envisagé
| |
Collapse
|
7
|
Seilan C, Dubuquoy C. Effects of oxysterols on arachidonic acid metabolism and prostacyclin synthesis in bovine aortic smooth muscle cells in culture. Prostaglandins Leukot Essent Fatty Acids 1990; 39:11-8. [PMID: 2111025 DOI: 10.1016/0952-3278(90)90165-h] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Previous studies have shown that oxysterols could induce arterial damage in animals and manifest potent toxicity in cultured cells. Bovine aortic smooth muscle cells in culture were used to study the effects of several cholesterol oxides on arachidonic acid (AA) metabolism. Using two different methods, i.e. radioactive labeling of cells with 14C-AA and radioimmunoassay of 6kPGF1 alpha, the stable metabolite of Prostacyclin (PGI2), we observed various effects depending on the substance. Oxysterols oxidised on the rings were able to inhibit AA metabolism only at high doses, toxic to the cells, presumably through a non specific lytic mechanism. Oxysterols oxidised on the side chain induced an inhibition of the overall arachidonate conversion and PGI2 synthesis at low doses, below the range of cytotoxicity. This inhibition was noted both on the basal and stimulated metabolism. Mechanisms involved in such actions are still to be determined.
Collapse
Affiliation(s)
- C Seilan
- INRA-Laboratoire des Sciences de la Consommation, Jouy en Josas, France
| | | |
Collapse
|
8
|
Coste M, Dubuquoy C, Tomé D. Effect of systemic and orally administered iota-carrageenan on ovalbumin-specific antibody response in the rat. Int Arch Allergy Appl Immunol 1989; 88:474-6. [PMID: 2722262 DOI: 10.1159/000234735] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Iota-carrageenans are high molecular weight polygalactans commonly used in the food industry. Their immunomodulating effects were examined on the reaginic and IgG ovalbumin-specific responses after systemic or oral administration to Brown Norway rats. Intraperitoneal injection of ovalbumin with either iota-carrageenan or alum induced both a reaginic and IgG response. Reaginic antibodies were detected in the primary response with alum, but only in the secondary response with iota-carrageenan. Oral tolerance to ovalbumin was similarly induced whether the protein was given alone or admixed in solution with iota-carrageenan. These results confirmed the systemic adjuvant action of iota-carrageenan described earlier, and showed that this effect did not take place when orally administered.
Collapse
Affiliation(s)
- M Coste
- Institut National de la Recherche agronomique, Laboratoire des Sciences de la Consommation, Jouy-en-Josas, France
| | | | | |
Collapse
|
9
|
Fenyo J, Selegny E, Gusmini S, Dubuquoy C. Séparation de lanthanides par chromatographie sur papier échangeur d'ions SA-2 en milieu α-hydroxyisobutyrique. J Chromatogr A 1970. [DOI: 10.1016/s0021-9673(00)93632-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|